Overview

DES Mothers (Women who took DES during pregnancy) have an increased risk of breast cancer. Studies suggest that these women have about a 30% higher risk of breast cancer compared to those who were not exposed to DES. This translates to approximately 1 in 6 DES-exposed mothers developing breast cancer over their lifetime, compared to 1 in 8 in the general female population.

This elevated risk appears to continue as DES Mothers age. However, DES exposure has not been linked to significant increases in other cancers or health issues beyond breast cancer. It is recommended that DES Mothers adhere to standard breast cancer screening guidelines and inform their healthcare providers about them.

If you’ve been affected and want to connect with others who understand what you’re going through, we encourage you to join a private and supportive Facebook group — run and moderated by a DES Daughter. It’s a safe space where you can share your experiences, ask questions, and find solidarity. You can also help us understand your situation better by completing our confidential client questionnaire.

Fill in our client questionnaire

Your voice matters, and we’re here to support you every step of the way.